UK trade body calls for focus on pharma ahead of general election

14 November 2019
abpi_logo_large-1--1

With a December general election looming in the UK, the British pharmaceutical industry has outlined its policy priorities, calling on political parties to support UK science and research.

Launching its  Manifesto for Medicine, the Association of the British Pharmaceutical Industry (ABPI) said the next government should seek to “maintain the UK’s position as a global leader in medicines and vaccines development into the future.”

The industry body is calling on all parties to prioritise patients and health security in the future UK – EU relationship.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical